Drug-eluting stents in clinical routine: a 1-year follow-up analysis based on German health insurance administrative data from 2008 to 2014

OBJECTIVES: To describe the use of drug-eluting stents (DESs) in the largest population of statutory health insurance members in Germany, including newly developed bio-resorbable vascular scaffolds (BVSs), and to evaluate 1-year complication rates of DES as compared with bare metal stents (BMSs) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeschke, Elke, Searle, Julia, Günster, Christian, Baberg, Henning Thomas, Dirschedl, Peter, Levenson, Benny, Malzahn, Jürgen, Mansky, Thomas, Möckel, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642747/
https://www.ncbi.nlm.nih.gov/pubmed/28756388
http://dx.doi.org/10.1136/bmjopen-2017-017460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642747/
https://www.ncbi.nlm.nih.gov/pubmed/28756388
http://dx.doi.org/10.1136/bmjopen-2017-017460

Ejemplares similares